Our mission is simple: Get our clients' products to market, and keep them there.
Since 1996, RQMIS has been providing companies with strategic guidance on how to effectively navigate the medical device, pharma, nutraceutical, and cosmetics regulations all around the globe. RQMIS currently has company locations in Boston (US), Barcelona (EU), and in London (UK).
RQMIS stands for "Regulatory/Quality Management Information Source". Our team of consultants is led by a former FDA reviewer from the Office of Device Evaluation, Boston district. Our regulatory consultancy focuses on four principal areas: Regulatory Strategy and Submissions, Clinical Study Design and Management, Quality Systems Design and Compliance, Insurance Reimbursement, Postmarket Surveillance, and Cybersecurity.
We operate as a family business, meaning our clients are always our first priority. We understand the frustration and confusion that comes with navigating the regulatory "red tape" which is why we're always available to our clients. We're not too busy to answer a phone call, email, or make an in-person visit. RQMIS is in this with you, and at the end of the day, we want to see you and your product succeed.
Our goal is always the same - to execute the most efficient and cost-effective commercialization pathway for our clients worldwide. We like to say we're a "one-stop-shop", offering not just Regulatory solutions but Quality and Clinical as well. Rather than educating our consultants on a wide range of specialties we prefer to work with a larger team where each person has their niche that they are expertly trained in. This means you're always getting 110% when you work with us.
We are proud to have a team from a wide range of backgrounds including SaMD, AI, cardiology, orthopedics, pharmacy, cosmetics, and nutrition in the veterinary and environmental fields.
If you are an expert consultant join the RQMIS family!
RQMIS Expertise By Market Segment
All Device Classes - I-III, Active Implantables, and Human Tissue
Bone Replacement Materials—Human Tissue/Synthetics/ Biologics (peptides, stem cells)
Internal/External Bone Growth Stimulators—Active Implantable
Sports Medicine
Paediatrics Skeletal Reconstruction
Hyaluronic Acid
Total Joint Prosthetics
External and Internal Trauma Implants
Bracing
Diazepam
Antibiotic Bone Cement
Gastroenterology/Urology/Pulmonology/Plastic Surgery
Hemodialysis Systems
Radiofrequency Ablation and Irreversible Electroporation
Endoscopy/Laparoscopy/Bronchoscopy and Accessories
Minimally Invasive Surgical Instruments/Implants
Biliary Stents
Ultrasonic Imaging
Ostomy Devices/Accessories
Sevoflurane
Auto-Injector
Picture Archiving and Capture Systems (PACS)
Infusion Pumps
Covid diagnostic test
Ventilators
Live bacteria for gut health improvement
Live bacteria treating asthma symptoms
Live bacteria for metabolic disorders
ENT
Lasers
Hearing Aids
Cochlear Implants
Cardiology
Stents (bare metal and drug-eluting)
Defibrillators
Ablation Systems
Cardiac Bio Prosthesis/Valve Replacement
Catheters
Tissue Regeneration
Oncology
HPV diagnostic product
Detecting Biomarkers in Humans
Infectious Disease Progenitor Monitoring
In-situ Device to measure metabolic activity of tumors
Oral/Maxillofacial/Dental
Dental Implants
TMJ Implants
Bone Filling/Augmentation Materials
Dental Restorative Materials
Orthodontics
In-situ Detection of Oral Cancer
OB/GYNO/Metabolism/Dermatology
Lubricants
Laparoscopy and Accessories
Blood glucose test
Breath air ketones test
Acne treatment
Atopic dermatitis treatment
Psoriasis treatment
Hirsutism treatment
Impetigo treatment
Live bacteria for skin improvement
Skin protection
Combination Products
Advance Therapy Medicinal Products (ATMP)
Drug/Device/Biologic Combination
IVD
Clinical laboratory testing
Near-patient testing
Self-testing
Technology
3D Printing Manufacturing
Spinal Implants
Total Joint Prosthetics
Bracing
Machine Learning/AI
Stroke Detection Devices
Pulmonary Measurement Device
Hemorrhage Detection Device
RQMIS Expertise By Business Support Services
Business Management
The overall integration of Regulatory/Clinical/Quality Processes/Functions into business processes
Acquisition Due Diligence – Regulatory/Clinical/Quality Focus
Product Management of Spinal Implants
Regulatory - United States
FDA Negotiations
Premarket Notifications (510(k)FDA) – Including Notes to File
Investigational Device Exemptions (IDE) and Supplements for FDA
Premarket Approval Applications (PMA) and Supplements for FDA
Labeling/Promotional Materials Review
FDA Medical Device Registration and Listing
Regulatory - EU / UK
CE Marking
UKCA Marking
Clinical Evaluation Reports
Medical Device Authorized Representatives (EUAR)
Medical Device Responsible Person (UKRP)
Postmarket Surveillance
Quality
Internal Audits
ISO 13485 Quality System Design/Compliance/Auditing
FDA QSR and Human Tissue GMP Design/Compliance/Auditing
FDA Negotiations/Responses to 483’s, Warning Letters, and Recalls
Postmarket Surveillance
Clinical
Overall Clinical Study Management – phase II, III, and Post-Marketing Surveillance
Study setup and CA/IRB/EC submissions
Protocol Management in the US, EU, Israel, Brazil, Turkey, and South Africa
Clinical Affairs Process Development and Procedures
Study Monitoring
Developed/Managed Data Safety Monitoring Boards
Clinical Report Writing
Protocol design/development
Case Report Form design/development
Insurance Reimbursement
Bioresearch Monitoring
Cybersecurity in Medical Devices
Web and mobile application penetration testing
Security and Information Event Management (SIEM) solutions
Remote Security Operations Center Team (SOC) to work with your IT organization to rapidly detect, triage, and aid in the remediation of security incidents
Consulting on cybersecurity requirements and best practices
Postmarket Surveillance
Properly categorizing and processing customer/employee feedback, repair processing, complaints
Serious injury/death reporting (e.g., MDR and Vigilance Reporting)
Health Hazard Analysis/Reports
Recalls
Postmarket Clinical Follow-up (PMCF) Studies
Review and analysis of published and unpublished clinical studies/experience
Clinical Evaluation Reports
Updating and maintaining the risk management profile of a family of products based on a comprehensive review of postmarketing data.
Technical Documentation for CE Marking, including product labeling
Trend analysis of Post Market data to determine the potential need for CAPAs
Review of clinical experience to determine potential new uses of existing products